SCHEMBL21990265

SCHEMBL21990265

CSc1ncc2cc(-c3ccc(Cl)cc3)c(=O)n(C)c2n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK2 O43353 3/20 0.53
ACVR1 Q04771 2/20 0.48
NOD2 Q9HC29 1/20 0.48
FGFR1 P11362 8/20 0.48
EGFR P00533 4/20 0.46
SRC P12931 3/20 0.46
FGFR2 P21802 3/20 0.46
FGFR4 P22455 3/20 0.46
FGFR3 P22607 3/20 0.46
PSEN1 P49768 1/20 0.45
PSEN2 P49810 1/20 0.45
APH1B Q8WW43 1/20 0.45
NCSTN Q92542 1/20 0.45
APH1A Q96BI3 1/20 0.45
PSENEN Q9NZ42 1/20 0.45
WEE1 P30291 2/20 0.44
STK4 Q13043 2/20 0.44
STK3 Q13188 2/20 0.44
SIK2 Q9H0K1 2/20 0.44
STK26 Q9P289 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29498168 1.00 RIPK2 (0.53) RIPK2ACVR1NOD2FGFR1EGFR
SCHEMBL20563514 0.88 RIPK2 (0.53) RIPK2ACVR1NOD2FGFR1EGFR
SCHEMBL21990257 0.87 ABL1 (0.53) RIPK2ACVR1NOD2FGFR1EGFR
SCHEMBL29498179 0.85 RIPK2 (0.54) RIPK2ACVR1NOD2FGFR1EGFR
SCHEMBL20564991 0.85 RIPK2 (0.50) RIPK2ACVR1NOD2FGFR1EGFR
SCHEMBL21990253 0.85 RIPK2 (0.54) RIPK2ACVR1NOD2FGFR1EGFR
SCHEMBL20564624 0.85 FGFR1 (0.56) RIPK2ACVR1NOD2FGFR1EGFR
SCHEMBL20564005 0.85 RIPK2 (0.54) RIPK2ACVR1NOD2FGFR1EGFR
SCHEMBL4283199 0.82 FGFR1 (0.45) RIPK2ACVR1FGFR1EGFRSRC
SCHEMBL20564958 0.82 RIPK2 (0.57) RIPK2ACVR1NOD2STK4STK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624032-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases UNIVERSITY OF HOUSTON SYSTEM (US) 2026-05-12 US disclosed
US-12516055-B2 Protein kinase inhibitors and uses thereof for the treatment of diseases and conditions TRUSTEES OF TUFTS COLLEGE (US) 2026-01-06 US disclosed
EP-4480485-A2 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS University of Houston System (US) 2024-12-25 EP disclosed
US-20240327403-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES UNIVERSITY OF HOUSTON SYSTEM (US) 2024-10-03 US disclosed
EP-3968991-B1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS UNIV HOUSTON SYSTEM (US) 2024-07-31 EP disclosed
US-12012402-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases UNIVERSITY OF HOUSTON SYSTEM (US) 2024-06-18 US disclosed
US-20220194937-A1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS UNIVERSITY OF HOUSTON SYSTEM 2022-06-23 US disclosed
US-20220064163-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES UNIVERSITY OF HOUSTON SYSTEM (US) 2022-03-03 US disclosed
US-11174255-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases UNIVERSITY OF HOUSTON SYSTEM (US) 2021-11-16 US disclosed
US-20200172536-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES UNIVERSITY OF HOUSTON SYSTEM (US) 2020-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174255-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases RIPK2, RIPK1, RIPK4 RIPK2 1/4885ACVR1 7/4885NOD2 499/4885
US-20200172536-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES RIPK2, RIPK1, RIPK4 RIPK2 1/4885ACVR1 7/4885NOD2 499/4885
US-20240327403-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES RIPK2, RIPK1, RIPK4 RIPK2 1/4885ACVR1 7/4885NOD2 538/4885
US-20220064163-A1 PYRIDO[2,3-d]PYRIMIDIN-7-ONES AND RELATED COMPOUNDS AS INHIBITORS OF PROTEIN KINASES RIPK2, RIPK1, RIPK4 RIPK2 1/4885ACVR1 7/4885NOD2 538/4885
US-12012402-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases RIPK2, RIPK1, RIPK4 RIPK2 1/4885ACVR1 7/4885NOD2 538/4885
US-20220194937-A1 PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS RIPK2, RIPK1, RIPK4 RIPK2 1/4885ACVR1 7/4885NOD2 295/4885
US-12624032-B2 Pyrido[2,3-d]pyrimidin-7-ones and related compounds as inhibitors of protein kinases RIPK2, RIPK1, RIPK4 RIPK2 1/4885ACVR1 21/4885NOD2 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.